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Abstract
Introduction: Low back pain (LBP) is a global health concern. Increasing evidence
implicates intervertebral disk (IVD) degeneration as a major contributor. In this
respect, tissue-specific progenitors may play a crucial role in tissue regeneration, as
these cells are perfectly adapted to their niche. Recently, a novel progenitor cell pop-
ulation was described in the nucleus pulposus (NP) that is positive for Tie2 marker.
These cells have self-renewal capacity and in vitro multipotency potential. However,
extremely low numbers of the NP progenitors limit the feasibility of cell therapy
strategies.
Objective: Here, we studied the influence of the culture method and of the microen-
vironment on the proliferation rate and the differentiation potential of human NP
progenitors in vitro.
Method: Cells were obtained from human NP tissue from trauma patients. Briefly,
the NP tissue cells were cultured in two-dimensional (2D) (monolayer) or three-
dimensional (3D) (alginate beads) conditions. After 1 week, cells from 2D or 3D cul-
ture were expanded on fibronectin-coated flasks. Subsequently, expanded NP cells
were then characterized by cytometry and tri-lineage differentiation, which was ana-
lyzed by qPCR and histology. Moreover, experiments using Tie2+ and Tie2− NP cells
were also performed.
Results: The present study aims to demonstrate that 3D expansion of NP cells better
preserves the Tie2+ cell populations and increases the chondrogenic and osteogenic
differentiation potential compared to 2D expansion. Moreover, the cell sorting exper-
iments reveal that only Tie2+ cells were able to maintain the pluripotent gene expres-
sion if cultured in 3D within alginate beads. Therefore, our results highly suggest that
the maintenance of the cell's multipotency is mainly, but not exclusively, due to the
higher presence of Tie2+ cells due to 3D culture.
Conclusion: This project not only might have a scientific impact by evaluating the
influence of a two-step expansion protocol on the functionality of NP progenitors,
but it could also lead to an innovative clinical approach.
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1 | INTRODUCTION
The intervertebral disk (IVD) consists of superior and inferior cartilagi-
nous endplates (CEP), outer annulus fibrosus (AF), and central gel-like
nucleus pulposus (NP). IVD degeneration is a major cause of lower
back pain, and the burdens caused by IVD degeneration-related mor-
bidities extend to society and the economy as a whole.1-4 Current
therapies cannot cure IVD degeneration and are limited to conserva-
tive treatments (such as medication or physical therapy) or surgical
interventions (such as spinal fusion).5 Regeneration therapy for IVD
degeneration mainly targets the NP tissue, as its degeneration is con-
sidered to be a major cause of low back pain.5,6 Therefore, under-
standing the cell morphology and gene expression profile of NP cells
(NPCs) is critical for developing new therapeutic strategies for IVD
regeneration.
The recent discovery of a new cell candidate for cell therapy, the
NP progenitor cell (NPPC), advances this research focus as this cell
type might be involved in the innate maintenance of disk health.7
These progenitor cells represent a rare subpopulation (between 1%
and 5%) of the total NP cell population and were shown to decrease
markedly with age and to be nearly absent in people >40 years of
age.7 However, NPPCs fulfilled formally progenitor criteria and pos-
sess the ability for multilineage differentiation.7,8 Such NPPCs were
identified and successfully isolated from human, bovine, murine, and
canine NP tissues using fluorescence-activated cell sorting (FACS)
through the angiopoietin-1 receptor (aka. Tie2).9 Nonetheless, it is still
to be clarified how this Tie2 positive (Tie2+) cells are related to mes-
enchymal stromal cells (MSCs) and the recently closer characterized
notochordal cells.10 Recently, a study reported the expression of two
classical MSC markers, CD29 and CD105, in NPPCs compared to
umbilical-cord-derived MSCs.11 These results were in accordance with
findings of niches for multipotent stem cells in the disk itself or possi-
bly in the nearby bone marrow of the vertebrae close to CEP
cells.12-14
The ability to culture and expand NPCs (and especially NPPCs),
while maintaining their gene expression profile and their stem poten-
tial is essential in experiments using these cells, as dysregulation of
multiple intracellular signaling pathways may play a key role in IVD
degeneration.15,16 Several cell based or cytokine therapies have been
investigated using rat, rabbit, bovine, mouse, and human NPC
culture,6,17-19 but molecular pathways such as NPC intracellular sig-
naling pathways are still not fully understood.1,5
Cell therapy seems to be a more promising approach for disk
regeneration. However, so far, there have been few reports using
human NPCs caused by the difficulty associated with harvesting ade-
quate quantities of these cells from available IVDs. Additionally,
despite their early fading, the study of this marginal subpopulation
within the NP might give rise to a better understanding of how these
cells affect IVD health, and what conditions will be optimal to extend
their number in vitro and to maintain them longer in their native stem
state. Moreover, a deeper understanding might lead to new
approaches for the regeneration of the IVD. Furthermore, the gene
expression profile of human NPCs is easily lost with conventional
two-dimensional (2D) monolayer culture, which does not replicate the
three-dimensional (3D) hydrophilic aggrecan-rich gelatinous extracel-
lular matrix (ECM) with unique avascular, hypoxic, nutrient-deficient,
high osmotic pressure characteristics in which NPCs are naturally
supported. Therefore, a novel culture method is required, which
allows for the number of NPCs to be expanded while maintaining
their gene expression profile. In this study, we aimed to establish an
in vitro culture method for human NPCs to maintain and increase the
amount of NPPCs over time. We also aimed to preserve the stem
potential of those cells regarding their multipotent gene expression
and phenotype but also their ability to differentiate into a
chondrogenic, adipogenic, and osteogenic lineage. Moreover, experi-
ments were performed in which NPCs were sorted into Tie2+ and
Tie2− subpopulations combined with our new culture method was
also performed to better understand the metabolism and gene expres-
sion profile of those cells under those specific conditions.
2 | MATERIALS AND METHODS
2.1 | Cell isolation
Human IVD tissue was obtained from 10 patients ranging from 20 to
70 years of age (mean ± SD [SD]) (36.81 ± 15.61 years) undergoing
spinal surgery after experiencing trauma to their disks. Immediately
after harvesting the IVDs, an experienced surgeon divided the tissues
into annulus fibrosus (AF), nucleus pulposus (NP), and cartilaginous
endplate (CEP). The tissues were subsequently processed in the labo-
ratory within 24 hours after surgery. Patients provided written con-
sent and the ethics committee of the Canton of Bern approved the
procedure (SwissEthics # 2019-00097).
First, the human disk cells were isolated from their native extra-
cellular matrix (ECM) by sequential digestion of the tissues with
1.9 mg/mL Pronase (Roche Diagnostics, Mannheim, Germany) for
1 hour and then with Collagenase type II (Worthington, London, UK)
at a concentration corresponding to the digested tissue (NP: 64 U/
mL, AF: 129 U/mL, CEP: 1562 U/mL per gram tissue) on a plate
shaker at 10 RPM at 37C, overnight. Remaining tissue fragments
were removed by using filtration through a 100 μm cell strainer
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(Falcon, Corning, New York). Right after isolation, NP cells were
expanded separately in the proliferation medium consisting of low-
glucose (1 g/L) Dulbecco's Modified Eagle Medium (LG-DMEM;
Gibco, Life Technologies, Zug, Switzerland), supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin/streptomycin/glutamine
(#10378016; 10 000 units of penicillin, 10 000 μg of streptomycin,
and 29.2 mg/mL of L-glutamine in a 10 mM citrate buffer; Merck,
Darmstadt, Germany). The AF and CEP cells were directly frozen and
stored right after isolation.
Concerning human bone marrow mesenchymal stromal cells
(hBMSCs), human bone marrow aspirates (20 mL) were obtained dur-
ing routine orthopedic surgical procedures on the same patients
described above undergoing spinal surgery after experiencing trauma
to their disks. After surgery, the bone marrow aspirate was immedi-
ately transferred into plastic tubes containing heparin, S-Monovette
(#01.1634; Sarstedt, Nümbrecht, Germany). After diluting the marrow
aspirates with phosphate-buffered saline (PBS) at a ratio of 1:4, nucle-
ated cells were isolated using a density gradient solution (Histopaque,
Sigma). The complete medium consisted of α-minimum essential
medium (αMEM) with 10% fetal bovine serum, 1% of
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (aka. HEPES) at
1 M, 1% sodium pyruvate (100 mM), and 1% of penicillin-
streptomycine-glutamine (100×) solution (P/S/G) (from Gibco and
Merck, respectively). Nucleated cells were plated at a density of
3.106 cells/cm2 in complete medium supplemented with 5 ng/mL of
fibroblast growth factor-2 (FGF-2; R&D Systems, Zug, Switzerland)
and cultured in a humidified incubator at 37C and 5% CO2. The
medium was changed twice a week. Here, hBMSCs were selected
based on adhesion and proliferation on the plastic substrate 1 week
after seeding and were used at passage 3.
2.2 | Cell culture
2.2.1 | Conventional 2D monolayer culture of
human nucleus pulposus cells
For the 2D culture in the first expansion phase, NP cells isolated from
IVDs were plated at 1 × 104 cells/cm2 on culture flask/dish (Techno
Plastic Products, Trasadingen, Switzerland) and cultured in LG-DMEM
with 10% fetal bovine serum, 1% HEPES (1 M), 1% sodium pyruvate
(100 mM), and 1% of PSG (100×) solution (all from Gibco) and
100 μM L-ascorbic acid-2-phosphate (Sigma-Aldrich) under a 5% CO2
and 5% oxygen atmosphere at 37C. The medium was replaced twice
a week until confluence.
2.2.2 | Primary 3D culture of human nucleus
pulposus cells in alginate beads
For the 3D culture in the first expansion phase, NP cells isolated from NP
tissue were washed with PBS and centrifuged at 1500 rpm for 3 minutes.
Cells were mixed and encapsulated in 1.2% alginate at a density of
4 × 106 cells/mL using a syringe (22 G needle) by forming approximately
30 μL droplets in a 102 mM CaCl2 salt solution.20 The NP cell alginate
beads (six beads per well of 12-well plate) were maintained in LG-DMEM
with 10% fetal bovine serum, 1% HEPES (1 M), 1% sodium pyruvate
(100 mM), and 1% of penicillin-streptomycin-glutamine (100×) solution
(all from Gibco) and 100 μM L-ascorbic acid-2-phosphate (Sigma-Aldrich)
under a 5% CO2 and 5% oxygen atmosphere at 37C, for 7 days. The
medium was replaced twice a week.
2.2.3 | For the second phase of expansion in 2D
monolayer for human nucleus pulposus cells
After 7 days of primary 2D conventional monolayer culture (first
expansion phase), NPCs were isolated from tissue culture dishes by
trypsinization, washed, and seeded back into tissue culture dishes
coated with fibronectin (#F2006, Sigma) at a density of
10 × 103 cells/cm2. Thereafter, 3D NP cell alginate beads were
digested in alginate dissociation buffer, composed of NaCl at 150 mM
(#71379, Sigma) and Na3Citrate.2H2O at 55 mM (#71406, Sigma) dis-
solved in Milli-Q-Water and adjusted at pH = 6.8, at 37C for
15 minutes. After washing, NPCs were seeded into a tissue culture
dish coated with fibronectin (#F2006, Sigma) at a density of
10 × 103 cells/cm2 with LG-DMEM with 10% fetal bovine serum, 1%
HEPES (1 M), 1% sodium pyruvate (100 mM), and 1% of penicillin-
streptomycin-glutamine (100×) solution (all from Gibco) and 10 ng/mL
of FGF-2 (R&D Systems) until confluence. After reaching confluence,
cells were directly used for the differentiation assays. Microscopic pic-
tures were taken for each condition at the end of the first and second
phase of expansion using the Nikon Eclipse E800 microscope (Nikon,
Tokyo, Japan).
2.3 | FACS analysis
The phenotype of NPCs was determined by cytofluorimetric analysis
with fluorochrome-conjugated antibodies against human CD90-FITC
(#555595) at 1:100, CD73-PE (#550257) at 1:100, CD105-Alexa488
(#MHCD10520) at 1:100, CD34-PECy5 (#555823) at 1:100,
CD45-PECy7 (#557748) at 1:100, CD146-BV605 (#7433019) at
1:100, and Tie2-PE (#FAB3131A) at 1:50 (all from BD Bioscience,
Franklin Lakes, NJ). Isotype IgG was used as a control (all from BD
Biosciences). Cells in suspension were incubated for 40 minutes with
each of these antibodies at 4C in FACS buffer (PBS, 0.5% human
serum albumin, 0.5 mm EDTA), and analyzed with a Cell Lab Quanta
SC flow cytometer (Beckman Coulter Inc.).
2.4 | Adipogenic differentiation
For adipogenic differentiation, NPCs were seeded at a density of
15 × 103 cells/cm2 in a 12-well plate (Techno Plastics Products, Inc.).
Cells were grown until 90% confluency was reached in monolayer
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culture in α-MEM supplemented with 10% FBS, Sigma-Aldrich, 1%
penicillin/streptomycin (P/S, 100 μg/mL and 100 IU/mL, respectively;
Merck), and 2.5 ng/mL fibroblast growth factor 2 (FGF2; #100-18B;
PeproTech, London, UK). The medium was then changed to
adipogenic differentiation medium (α-MEM with 10% FCS, 1% P/S,
12.5 μM insulin, 100 nM dexamethasone, 0.5 mM 3-isobutyl-
1-methylxanthine, and 60 μM indomethacin [all from Sigma-Aldrich])
and incubated for 21 days under a 5% CO2 and 20% oxygen atmo-
sphere at 37C.21 NPCs that were kept in complete medium (α-MEM
supplemented with 10% FBS, Sigma-Aldrich, 1% penicillin/streptomy-
cin [P/S, 100 μg/mL and 100 IU/mL, respectively; Merck ]) were used
as control. The medium was changed twice a week, and samples were
carried out in technical duplicates (ie, in two wells).
Adipogenic differentiation was evaluated by light microscopy
after staining the lipid vacuoles with Oil Red O (Merck). Samples were
fixed with 4% formaldehyde; the cell layer was rinsed with 50% EtOH
and stained for 20 minutes with 0.2% (w/v) Oil Red O in 60% (v/v)
2-propanol (Sigma-Aldrich). The lipid droplet formation was then visu-
alized under a stereomicroscope (Nikon Eclipse E800) and photo-
graphed. For quantification purposes, the Oil Red O was also
extracted with 100% 2-propanol and then analyzed by measuring the
absorbance at 500 nm with the microplate reader SpectraMax M5
(Molecular Devices, San Jose, California, distributed by Bucher Biotec,
Basel, Switzerland).
2.5 | Osteogenic differentiation
For osteogenic differentiation, NPCs were seeded at a density of
15 × 103 cells/cm2 in a 12-well plate (Techno Plastics Products, Inc.).
Cells were grown until 90% confluency was reached in monolayer cul-
ture using an expansion medium (α-MEM supplemented with 10%
FBS, Sigma-Aldrich, 1% penicillin/streptomycin [P/S, 100 μg/mL and
100 IU/mL, respectively; Merck ], and 2.5 ng/mL fibroblast growth
factor 2 [FGF2; #100-18B; PeproTech]). For differentiation, the
medium was changed to an osteogenic medium that consisted of
α-MEM supplemented with 1% P/S, 10% FCS, 100 nM dexametha-
sone, 10 mM β-glycerophosphate, and 50 μM L-ascorbic acid-
2-phosphate (all from Sigma-Aldrich).22 NPCs in complete medium
(α-MEM supplemented with 10% FBS, Sigma-Aldrich, 1% penicillin/
streptomycin [P/S, 100 μg/mL and 100 IU/mL, respectively; Merck ]),
seeded at the same density were used as control. The culture was
maintained for 21 days under a 5% CO2 and 20% oxygen atmosphere
at 37C, and the medium was refreshed twice a week. The differentia-
tion assay was carried out with two technical duplicates.
The cells were fixed in 4% formaldehyde, and the calcium deposi-
tion of the cell layers was evaluated with 2% Alizarin red staining
(ALZR) solution (Sigma-Aldrich) for 45 minutes. The ALZR was
released from the cell layers by the addition of a 10% cetylpyridinium
chloride solution (Sigma-Aldrich) for 1 hour under agitation. Optical
density was measured at 570 nm with the microplate reader
SpectraMax M5.
2.6 | Chondrogenic differentiation
For chondrogenic differentiation, 300 000 NP cells were seeded as a
cell pellet into 1.5 mL Eppendorf tubes for 21 days in chondrogenic
medium (HG-DMEM supplemented with 1% Pen/Strep, 100 nM
dexamethasone, 1% insulin-transferrin-sodium selenite [ITS+, cat. no.
I2521; Sigma-Aldrich], 1% nonessential amino acids (Gibco, Thermo
Fisher Scientific, Basel, Switzerland), 250 μM ascorbic acid, 10 ng/
mL transforming growth factor-beta 3 [TGF-β3; Peprotech]) or in con-
trol medium (serum-free medium,ie, HG-DMEM supplemented with
ITS+ with 1% P/S), and cultured for 21 days.23,24 The medium was
changed twice a week, and samples were carried out with biological
duplicates. The formed pellets were fixed in 4% formaldehyde for
overnight and then embedded in paraffin. Thereafter, 6 μm thin sec-
tions were cut with a microtome (Microm HM355; Thermo Fisher
Scientific).
The sample sections were stained with 0.02% Fast Green solution
(Merck) for 10 minutes. Then they were rinsed with 1% acetic acid
and then immersed in 0.1% Safranin-O (Merck) at pH 2.5 for
15 minutes to stain sulfated glycosaminoglycans (GAGs). Additionally,
sections were stained for sulfated GAGs with 1% Alcian blue 8GX
(Sigma-Aldrich) in 3% acetic acid at pH 1.0.25 Once dehydrated and
mounted, slides were imaged using an inverted microscope (Eclipse
E800; Nikon), and single images were taken at ×4 magnification and
stitched together using NIS Elements microscope imaging software
(Nikon) and edited for easier comparison with ImageJ 1.51j8 (Rasband
WS, 2020, ImageJ, National Institutes of Health, Bethesda, Maryland,
http://rsb.info.nih.gov/ij/).
2.7 | Cell sorting
Tie2+ cells were sorted using FACS as previously described.8,9,26
Freshly isolated NPCs (N = 3) were incubated with an anti-human
Tie2 PE-conjugated monoclonal mouse antibody (#FAB3131P, clone
83 715, R&D systems) for 30 minutes on ice in 100 μL of FACS
buffer ([PBS] with 0.5% bovine serum albumin [BSA] and 1 mM EDTA,
all from Sigma-Aldrich), protected from light. Propidium iodide (Sigma-
Aldrich) was used to exclude dead cells. Cell sorting was performed by
FACS Diva III (BD Biosciences) based on the procedure previously
reported.26 The Mouse IgG1 PE-conjugated Antibody (#IC002P, clone
11 711, R&D systems) was used as isotype control to set the gate for
sorting.
2.8 | Qantitative polymerase chain reaction
Concerning the analysis of 2D vs 3D culture during the second phase
of expansion, the gene expression of several major pluripotent genes
(homeobox protein NANOG [NANOG], octamer-binding transcription
factor 4 [OCT4], sex-determining region Y-box 2 [SOX2]) was analyzed
using quantitative polymerase chain reaction (qPCR).
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For the three differentiation assays, adipogenic related gene
expression (peroxisome proliferator-activated receptor gamma
[PPARγ], CCAAT/enhancer-binding protein alpha [CEBPα], and
adiponectin [ADIPOQ]), osteogenic related gene expression collagen
type I [COL1], Runt-related transcription factor 2 [RUNX2], alkaline
phosphatase [ALPL], osterix [SP7], osteocalcin [OCN] and osteopontin
[OPN]) and chondrogenic related gene expression (aggrecan [ACAN],
collagen type II [COL2], collagen type X [COL10], transcription factor
SOX-9 [SOX2], and transforming growth factor-beta 1 [TGF-β1]) were
analyzed using quantitative polymerase chain reaction (qPCR).
RNA isolation was performed as previously described.27 DNase
(DNase 1 Kit, Sigma-Aldrich) was used to degrade residual DNA, and
iScript cDNA Synthesis Kit (Bio-Rad Inc., Switzerland) was used for
reverse transcription. Thereafter, the cDNA was mixed with iTaq uni-
versal SYBR Green Supermix (Bio-Rad) and with forward and reverse
primers (Microsynth, Switzerland) for each gene (Table 1). qPCR was
performed in duplicates (CFX96 Touch, Bio-Rad) using 18S and
GAPDH as reference genes. The relative gene expression was deter-
mined using the 2−ΔΔCt method,28 and data were normalized to the
control condition (hBMSCs in complete medium or NP cells in 2D
culture).
2.9 | Cell activity
Mitochondrial activity was determined with the Alamar Blue assay
using 50 μM resazurin sodium salt (Sigma-Aldrich, Switzerland). Sam-
ples were incubated with the complete medium containing 10% of
50 μM resazurin solution for 3 hours before reading relative fluores-
cence units (RFUs) at an excitation wavelength of 547 nm and an
TABLE 1 Overview of all genes used for RT-Q-PCR in this study
Gene Description Forward primer (50-30) Reverse primer (30-50)
Reference genes
18S 18S ribosomal RNA CGA TGC GGC GGC GTT ATT C TCT GTC AAT CCT GTC CGT GTC C
GAPDH Glyceraldehyde 3-phosphate
dehydrogenase
ATC TTC CAG GAG CGA GAT GGA GGC ATT GCT GAT GAT
Pluripotent-related genes
NANOG Nanog homeobox CCG AAG AAT AGC AAT GGT CTG GTG GTA GGA AGA GTA
OCT4 Octamer-binding transcription factor 4 CGA TCA AGC AGC GAC TAT G GCC AGA GGA AAG GAC ACT
SOX2 SRY (sex determining region Y)-box 2 AGA GAG AAA GAA AGG GAG AGA A GCC GCC GAT GAT TGT TAT
TEK Angiopoietin-1 receptor (Tie2) TTA GCC AGC TTA GTT CTC TGT GG AGC ATC AGA TAC AAG AGG TAG GG
Adipogenic lineage-related genes
PPARγ Peroxisome proliferator-activated
receptor gamma
ACG AAG ACA TTC CAT TCA CAA GA CTC CAC AGA CAC GAC ATT CAA
CEPBα CCAAT/enhancer-binding protein alpha CAA GAA CAG CAA CGA GTA GTC ATT GTC ACT GGT CAG
ADIPOQ Adiponectin CCG TGA TGG CAG AGA TGG TAT ACA TAG GCA CCT TCT CCA G
Chondrogenic lineage-related genes
SOX9 Transcription factor SOX-9 GAG ACT TCT GAA CGA GAG GGC TGG TAC TTG TAA TCC
TGF-β1 Transforming growth factor-beta 1 CGT GCT AAT GGT GGA AAC GCT CTG ATG TGT TGA AGA AC
COL2 Collagen type 2 A1 AGC AGC AAG AGC AAG GAG AA GTA GGA AGG TCA TCT GGA
COL10 Collagen type 10 A1 GAA TGC CTG TGT CTG CTT TCA TAA TGC TGT TGC CTG TTA
ACAN Aggrecan CAT CAC TGC AGC TGT CAC AGC AGC ACT ACC TCC TTC
Osteogenic lineage-related genes
ALPL Alkaline phosphatase CCT TCA CTG CCA TCC TGT A CGC CTG GTA GTT GTT GTG
RUNX2 Runt-related transcription factor 2 AGC AGC ACT CCA TAT CTC T TTC CAT CAG CGT CAA CAC
OCN Osteocalcin GCA GAG TCC AGC AAA GGT G CCA GCC ATT GAT ACA GGT AGC
OPN Osteopontin ACG CCG ACC AAG GAA AAC TC GTC CAT AAA CCA CAC TAT CAC CTC G
COL1 Collagen type 1 A2 GTG GCA GTG ATG GAA GTG CAC CAG TAA GGC CGT TTG
SP7 Osterix CAG GCT ATG CTA ATG ATT ACC GGC AGA CAG TCA GAA GAG
Note: As reference genes: 18S (18S ribosomal RNA) and GAPDH (glyceraldehyde 3-phosphate dehydrogenase). Genes analyzed for pluripotent markers:
NANOG (nanog homeobox), OCT4 (octamer-binding transcription factor 4), SOX2 (Sex determining region Y-box 2), and TEK (angiopoietin-1 receptor).
Genes analyzed for the adipogenic lineage: PPARγ (peroxisome proliferator-activated receptor gamma), CEBPα (CCAAT/enhancer-binding protein alpha),
and ADIPOQ (adiponectin). Genes analyzed for the chondrogenic lineage: SOX9 (transcription factor Sox-9), TGF-β1 (transforming growth factor-beta 1),
COL2 (collagen type II), COL10 (collagen type X), and ACAN (Aggrecan). Genes analyzed for the osteogenic lineage: ALPL (alkaline phosphatase), RUNX2
(runt-related transcription factor 2), OCN (osteocalcin), OPN (osteopontin), COL1 (collagen type I), and SP7 (Osterix).
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emission wavelength of 582 nm on an ELISA reader (SpectraMax M5,
Molecular Devices Switzerland). Data were normalized to the amount
of DNA in each culture condition, at each time point.
2.10 | DNA content
Samples were digested overnight at 60C with 3.9 U/mL papain from
Papaya latex (Sigma-Aldrich). DNA was measured by a bisbenzimide
fluorescent dye (Hoechst 3258; Sigma-Aldrich) at 350 nm excitation
and 450 nm emission wavelength using a SpectraMax M5 plate
reader. A standard curve from calf thymus DNA (Sigma-Aldrich) was
used. Data were normalized to the amount of cells that were seeded
in each culture condition.
2.11 | GAG content
The same papain digested samples were used to determine the
amount of GAG and proteoglycans. For this, 1,9-dimethyl-methylene
blue (Sigma-Aldrich) was used, and absorbance was read at 600 nm
with a SpectraMax M5 plate reader.29 GAG content was calculated
from a standard curve obtained from chondroitin sulfate (Sigma-
Aldrich). Data were normalized to the amount of cells that were
seeded in each culture condition.
2.12 | Statistical analysis
Data are presented as mean ± SD (SD). For all data, a nonparametric
distribution was assumed. The percentage of cells positive after cyto-
metry analysis was analyzed by Kruskal-Wallis tests and Dunn's multi-
ple comparisons tests. Alizarin Red, Oil-Red-O, GAG, and Alamar Blue
quantification were analyzed by Kruskal-Wallis tests and Dunn's mul-
tiple comparisons tests. The relative gene expression was analyzed by
two-way ANOVA followed by a Dunnett multiple comparison test. A
P-value <.05 was considered significant. Asterisks within figures
denote degree of statistical relevance observed: * <.05; ** <.01;
***< .001; ****< .0001. The analysis was performed using GraphPad
Prism (version 8.0, GraphPad Prism Software, Inc.).
F IGURE 1 Microscopic analysis of NP cells during the first and second phase of Expansion. A-L, Microscopic analysis of human NP cells
seeded within different conditions. A, E, and I, Human NP cells seeded in two-dimensional (2D) with a culture medium supplemented with
ascorbic acid. B, F, J, Human NP cells seeded in three-dimensional (3D) (alginate beads) with a culture medium supplemented in ascorbic acid. C,
G, K, Human NP cells seeded 2D and then in 2D on fibronectin-coated flasks with fibroblast growth factor (FGF-2) supplemented culture
medium. D, H, L, Human NP cells seeded 3D and then in 2D on fibronectin-coated flasks with FGF-2 supplemented culture medium. Scale bar:
For pictures, A, until, L, the scale bar represents 150 μm
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F IGURE 2 Legend on next page.
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3 | RESULTS
3.1 | Conventional 2D monolayer culture vs 3D
culture into alginate beads
To find a better way to culture NPCs, we were following a two-step
protocol. Microscopic pictures of the NPCs were taken at each round
of this two-step protocol (Figure 1). Briefly, during the first phase of
expansion, we observed that NPCs formed a monolayer when cultur-
ing them in 2D with ascorbic acid supplemented medium (Figure 1A,E,
I). However, if cells were within alginate beads with ascorbic acid sup-
plemented medium NPCs presented a round shape in the hydrogel
(Figure 1B,F,J). During the second phase of expansion, NPCs that
were previously cultured in 2D and then in 2D on a fibronectin-
coated surface with FGF-2 supplemented medium presented a stro-
mal phenotype (Figure 1C,K), as NPCs that were previously cultured
in 3D and then in 2D on a fibronectin-coated surface with FGF-2 sup-
plemented medium (Figure 1D,H,L). For the first step (first expansion
phase), after dissecting the IVD and digesting of the nucleus pulposus
(NP) tissue, NPCs were seeded in 2D as a monolayer or in 3D into
alginate beads (Figure 2A).
After 1 week (to 1.5 weeks depending on the proliferation rate)
of culture, NPCs cultured in 2D as a monolayer and 3D within alginate
beads were analyzed by flow cytometry (Figure 2B-H). In both condi-
tions (2D or 3D), all NPCs were positive for CD90, CD75 and CD105
(Figure 2B-D). In the same way, NPCs in 2D or in 3D were both
expressing CD45 (50 ± 5%) (Figure 2E) and CD146 (25 ± 3%)
(Figure 2G). In contrast, only cells cultured in 3D (alginate beads) were
significantly positive for CD34 (10 ± 5%) (Figure 2F) and the Tie2
marker (45 ± 5%) (Figure 2H).
Concerning the relative expression of pluripotent genes and Tie2
(aka. TEK gene), 2D and 3D related samples were analyzed after
1 week of in vitro culture by qPCR (Figure 2I-L). The relative gene
expression of NANOG (Figure 2I), SOX2 (Figure 2J), OCT4 (Figure 2K),
and Tie2 (aka. TEK gene) (Figure 2L) was significantly higher (27-,
107-, 531-, and 193-fold increase, respectively) in NPCs that were
cultured culture into alginates beads compared to 2D culture on tissue
culture flask.
3.2 | NPCs maintained their gene expression
profile and NPPCs proliferated when cultured back
in 2D
For the second step (second expansion phase), following the first
phase of expansion, NPCs cultured in 2D monolayer or 3D alginate
beads were put back in 2D fibronectin-coated flasks (Figure 2M).
To further increase the number of human NPCs, after the first
phase of expansion (in 2D or 3D), we performed the second phase of
expansion in 2D using fibronectin-coated dishes with FGF-2 sup-
plemented medium. The analysis performed was the same as the one
used for the first expansion phase, meaning flow cytometry
(Figure 2N-S) and qPCR (Figure 2T-W).
Concerning the surface markers, all NPCs were positive for
CD90, CD75, and CD105 (Figure 2N-P) for both conditions (cell cul-
ture in 2D or 3D in the first expansion phase). In the same way, NPCs
that were cultured in 2D or 3D both expressed CD45 (70 ± 7%)
(Figure 2Q). In contrast, only cells cultured previously in 3D (alginate
beads) were significantly positive for CD34 (3.5 ± 0.5%) (Figure 2R)
and Tie2 marker (75 ± 20%) (Figure 2S).
Concerning the relative expression of pluripotent genes and Tie2
(Figure 2T-W), the expression of NANOG (Figure 2T) and OCT4
(Figure 2V) was similar in NPCs for both conditions (cells culture in 2D
or 3D in the first expansion phase). However, the relative gene
expression of SOX2 (Figure 2U) and Tie2 (aka. TEK gene) (Figure 2W)
was still significantly higher (1.4- and 2.5-fold increase, respectively)
in NPCs cultured in alginates beads compared to 2D culture on tissue
culture flasks.
3.3 | Adipogenic differentiation of NPCs
Next, we aimed to differentiate the expanded NPCs (from second
expansion phase) into an adipogenic lineage and to compare them
with hBMSCs. After 21 days of culture, Oil-Red-O staining was per-
formed and a macroscopic (Figure 3A-F) and microscopic (Figure 3G-
L) representation of this assay are shown. At a macroscopic and
microscopic level, we observed stained lipid droplets (in red/pink) only
F IGURE 2 Analysis of NP cells after the first and second phase of expansion. A, Schematic representation of the first phase of expansion of
nucleus pulposus (NP) cells. Briefly, after dissection and digestion of the NP tissue from the intervertebral disk (IVD), NP cells were seeded in
two-dimensional (2D) or three-dimensional (3D) into alginate beads. B-H, Quantification by flow cytometry analysis of the amount of NP cells
positive for different markers after culture in 2D or 3D for 1 week of culture. B-H, Percentage of NP cells positive in 2D or 3D for, B, CD90
marker, C, CD73 marker, D, CD105 marker, E, CD45 marker, F, CD34 marker, G, CD146 marker, and, H, Tie2 marker. I-L, Quantification of the
relative gene on NP cells for different genes after culture in 2D or 3D for 1 week of culture. I, Relative gene expression of NANOG in NP cells in
2D or 3D. J, Relative gene expression of SOX2 in NP cells in 2D or 3D. K, Relative gene expression of OCT4 in NP cells in 2D or 3D. L, Relative
gene expression of TEK in NP cells in 2D or 3D. M, Schematic representation of the second phase of expansion of NP cells. Briefly, after the first
phase of expansion, NP cells cultured in 2D or 3D were putting back in the fibronectin-coated flask/surface. N-S, Quantification by flow cytometry
analysis of the amount of NP cells (previously cultivated in 2D or 3D) positive for different markers after culture in the fibronectin-coated surface for
1 week of culture for, N, CD90 marker, O, CD73 marker, P, CD105 marker, Q, CD45 marker, R, CD34 marker, and, S, Tie2 marker. T-W,
Quantification of the relative gene on NP cells (previously cultivated in 2D or 3D) for different genes after culture on the fibronectin-coated surface.
T, Relative gene expression of NANOG in NP cells. U, Relative gene expression of SOX2 in NP cells. V, Relative gene expression of OCT4 in NP cells.
W, Relative gene expression of TEK in NP cells (n = 6) for each gene. Data are presented as mean ± SD. NP cells cultured in 2D during the first
expansion phase = blue bars. NP cells cultured in 3D during the first expansion phase = red bars. Tie2, angiopoietin-1 receptor; NANOG, homeobox
protein NANOG; SOX2, SRY (sex-determining region Y)-box 2; OCT4, octamer-binding transcription factor 4; TEK, angiopoietin-1 receptor
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with cells cultured with adipogenic medium (Figure 3A-C and
Figure 3G-I) and no evidence with cells cultured with the control
medium (Figure 3D-F,J-L).
After quantifying the Oil-Red-O stain (Figure 3M), we could
observe that a higher amount was stained with hBMSCs and 3D NPCs
compared to 2D NPCs (1.7-fold increase for both).
Regarding the relative gene expression of adipogenic markers,
PPARγ (Figure 3N), CEPBα (Figure 3O), and ADIPOQ (Figure 3P) were
all highly expressed in the condition treated with adipogenic medium
compared to control medium, for hBMSCs, NPCs cultured in 2D (aka.
NP (2D)) and NPCs cultured in 3D (aka. NP [3D]).
3.4 | Osteogenic differentiation of NPCs
Afterwards, we attempted to differentiate the expanded NPCs (at the
end of the second expansion phase) into an osteogenic lineage
compared to hBMSCs. After 21 days of culture, ALZR staining was
performed and a representation of this assay is shown (Figure 4A-F).
We could observe a coloration of the mineralized extracellular matrix
(in red) only in the wells containing cells cultured with osteogenic
medium (Figure 4A-C) compared to the control medium (Figure 4D-F),
for hBMSCs, NPCs cultured in 2D (aka. NP [2D]) and NPCs cultured
in 3D (aka. NP [3D]).
After quantification of the ALZR stain by re-solubilizing the color-
ation (Figure 4G), we could observe a significantly higher amount
(at least a twofold increase) of stained cells with hBMSC, NP (2D) cell,
and NP (3D) cell cultures with osteogenic medium compared to the
same cells in the control medium.
Regarding the relative gene expression of osteogenic markers, we
could observe an up-regulation (between 5- and 10-fold increase) of ALPL
(Figure 4H) for hBMSCs, NP (2D) cells, and NP (3D) cells cultivated in the
osteogenic medium in comparison to control medium. Concerning COL1
(Figure 4I) and OCN (Figure 4K), no differences were observed. Else ways,
F IGURE 3 Adipogenic differentiation of NP cells at the end of the second expansion phase. A-C, Macroscopic analysis of Oil-Red-O staining
after 21 days of culture into the adipogenic medium for, A, human Bone marrow mesenchymal stromal cells (hBMSCs), B, nucleus pulposus
(NP) cells previously cultured in two-dimensional (2D) (NP [2D]), and, C, NP cells previously cultured in three-dimensional (3D) (NP [3D]). D-F,
Macroscopic analysis of Oil-Red-O staining after 21 days of culture into control medium for, D, hBMSCs, E, NP cells previously cultured in 2D
(NP [2D]), and, F, NP cells previously cultured in 3D (NP [3D]). G-L, Microscopic analysis of Oil-Red-O staining after 21 days of culture into the
adipogenic medium for, G, hBMSCs, H, NP cells previously cultured in 2D (NP [2D]) and, I, NP cells previously cultured in 3D (NP [3D]). J-L,
Macroscopic analysis of Oil-Red-O staining after 21 days of culture into control medium for, J, hBMSCs, K, NP cells previously cultured in 2D
(NP [2D]), and, L, NP cells previously cultured in 3D (NP [3D]). M, Quantification of Oil-Red-O staining for hBMSCs, NP cells previously cultured
in 2D (NP [2D]), and NP cells previously cultured in 3D (NP [3D]) after 21 days in the adipogenic and control medium. N-P, Quantification of the
relative gene on NP cells (previously cultivated in 2D or 3D) for different adipogenic related genes after culture on the fibronectin-coated surface
with the adipogenic or control medium. N, Relative gene expression of peroxisome proliferator-activated receptor gamma (PPARγ) in NP cells. O,
Relative gene expression of CCAAT/enhancer-binding protein alpha (CEPBα) in NP cells. P, Relative gene expression of adiponectin (ADIPOQ) in
NP cells (n = 6) for each gene. Data are presented as mean ± SD. NP cells cultured in the control medium = blue bars. NP cells cultured in the
adipogenic medium = yellow bars. Scale bar: For pictures, G, until, L, the scale bar represent 100 μm
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looking at SP7 (Figure 4J), RUNX2 (Figure 4L), and OPN (Figure 4M) we
could note than only the NP (3D) cells were showing a significant increase
of relative gene expression of those genes (40-, 3-, and 187-fold increase,
respectively) in the condition treated with osteogenic medium compared
to the control medium.
3.5 | Chondrogenic differentiation of NPCs
Subsequently, we tried to differentiate the expanded NPCs (at the
end of the second expansion phase) toward a chondrogenic lineage
and compared the results with hBMSCs. After 21 days of culture,
samples were fixed and analyzed macroscopically (Figure 5A-F). After
21 days, cell pellets cultured in the chondrogenic medium (Figure 5A-
C) were bigger and whiter than cells cultured in the control medium
(Figure 5D-F). Thereafter, we also quantified the GAG content in the
supernatant (Figure 5G). We showed that the amount of GAG was
significantly higher (10 μg/mL compared to 0.5 μg/mL) in the NP
(3D) cells cultured with chondrogenic medium compared to the con-
trol medium (Figure 5G).
To continue to analyze those samples, two histological colora-
tions were performed: Alcian Blue (Figure 5H-M) and Safranin-O
coupled with Fast Green (Figure 5N-S), and sections were analyzed
microscopically. For the Alcian Blue staining, we could observe a
stronger intensity of blue stain, showing the presence of proteo-
glycan components, for the constructs that were cultured in the
chondrogenic medium (Figure 5H-J) compared to the same cells
cultured in the control medium (Figure 5K-M). Concerning the
Safranin-O staining, we noticed a stronger intensity of red/orange
stain, showing the presence of GAG, for the constructs that were
cultured in the chondrogenic medium (Figure 5N-P) compared to
the same cells cultured in the control medium (Figure 5Q-S). More-
over, as described above, the size of the constructs/cell pellets,
especially in the NP (3D) cell conditions cultured with the
chondrogenic medium were bigger and were presenting a “donut”
shape (Figure 5J,P).
F IGURE 4 Osteogenic differentiation of NP cells at the end of the second expansion phase. A-C, Macroscopic analysis of Alizarin Red
staining after 21 days of culture into the osteogenic medium for, A, human bone marrow mesenchymal stromal cells (hBMSCs), B, nucleus
pulposus (NP) cells previously cultured in two-dimensional (2D) (NP [2D]), and, C, NP cells previously cultured in three-dimensional
(3D) (NP [3D]). D-F, Macroscopic analysis of Alizarin Red staining after 21 days of culture into the control medium for, D, hBMSCs, E, NP cells
previously cultured in 2D (NP [2D]), and, F, NP cells previously cultured in 3D (NP [3D]). G, Quantification of Alizarin Red staining for hBMSCs,
NP cells previously cultured in 2D (NP [2D]), and NP cells previously cultured in 3D (NP [3D]) after 21 days in the osteogenic and control
medium. H-M, Quantification of the relative gene on NP cells (previously cultivated in 2D or 3D) for different osteogenic related genes after
culture on the fibronectin-coated surface with the osteogenic or control medium. H, Relative gene expression of alkaline phosphatase (ALPL) in
NP cells. I, Relative gene expression of collagen type I (COL1) in NP cells. J, Relative gene expression of osterix (SP7) in NP cells. K, Relative gene
expression of osteocalcin (OCN) in NP cells. L, Relative gene expression of runt-related transcription factor 2 (RUNX2) in NP cells. M, Relative
gene expression of osteopontin (OPN) in NP cells (n = 5) for each gene. Data are presented as mean ± SD. NP cells cultured in the control
medium = blue bars. NP cells cultured in the osteogenic medium = red bars
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Concerning the relative gene expression of chondrogenic
markers, we saw an up-regulation (fourfold increase) of ACAN
(Figure 5T) only for hBMSCs cultivated in the chondrogenic medium
in comparison to the control medium. Regarding SOX9 (Figure 5U)
and RUNX2 (Figure 5V), no differences were observed in any condi-
tions. To continue, COL10 (Figure 5W), a marker of hypertrophic dif-
ferentiation, we could see an up-regulation for all conditions
compared to hBMSCs cultured in control medium, NP (2D) cells, and
F IGURE 5 Legend on next page.
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NP (3D) cells (30, 300 and 200-fold increase, respectively). Looking at
COL2 (Figure 5X) only NPCs cultured in 2D or 3D was showing an up-
regulation (78 and 8000-fold increase, respectively) compared to the
control medium condition. For COL1 (Figure 5Y) an up-regulation for
hBMSCs and 2D NPCs (fivefold increase, for both) was found in the
condition treated with chondrogenic medium compared to the control
medium.
3.6 | Expression of TEK gene (aka. Tie2) after
differentiation
To explore the behavior of Tie2+ cells, the relative gene expression
of TEK was quantified after 21 days of adipogenic (Figure 6A),
osteogenic (Figure 6B), and chondrogenic (Figure 6C) differentia-
tion of hBMSCs, NP (2D) cells, and NP (3D) cells. No significant
F IGURE 5 Chondrogenic differentiation of nucleus pulposus (NP) cells at the end of the second expansion phase. A-C, Macroscopic analysis
of samples fixed after 21 days of culture into chondrogenic medium for, A, human bone marrow mesenchymal stromal cells (hBMSCs), B, NP cells
previously cultured in two-dimensional (2D) (NP [2D]), and, C, NP cells previously cultured in three-dimensional (3D) (NP [3D]). D-F, Macroscopic
analysis of samples fixed after 21 days of culture into control medium for, D, hBMSCs, E, NP cells previously cultured in 2D (NP [2D]), and, F, NP
cells previously cultured in 3D (NP [3D]). G, Quantification of GAG into culture supernatant for hBMSCs, NP cells previously cultured in 2D
(NP [2D]), and NP cells previously cultured in 3D (NP [3D]) after 21 days in chondrogenic and control Medium. H-M, Microscopic analysis of
Alcian Blue staining after 21 days of culture into chondrogenic medium for, H, hBMSCs, I, NP cells previously cultured in 2D (NP [2D]) and, J, NP
cells previously cultured in 3D (NP [3D]). K-M, Macroscopic analysis of Alcian Blue staining after 21 days of culture into control medium for, K,
hBMSCs, L, NP cells previously cultured in 2D (NP [2D]), and, M, NP cells previously cultured in 3D (NP [3D]). N-P, Microscopic analysis of
Safranin-O and Fast Green staining after 21 days of culture into chondrogenic medium for, N, hBMSCs, O, NP cells previously cultured in 2D
(NP [2D]), and P, NP cells previously cultured in 3D (NP [3D]). Q-S, Macroscopic analysis of Safranin-O and Fast Green staining after 21 days of
culture into control medium for, Q, hBMSCs, R, NP cells previously cultured in 2D (NP [2D]) and, S, NP cells previously cultured in 3D (NP [3D]).
T-Y, Quantification of the relative gene on NP cells (previously cultivated in 2D or 3D) for different chondrogenic-related genes after culture on
the fibronectin-coated surface with chondrogenic or control medium. T, Relative gene expression of aggrecan (ACAN) in NP cells. U, Relative gene
expression of transcription factor Sox-9 (SOX9) in NP cells. V, Relative gene expression of runt-related transcription factor 2 (RUNX2) in NP
cells. W, Relative gene expression of collagen type X (COL10) in NP cells. X, Relative gene expression of collagen type II (COL2) in NP cells. Y,
Relative gene expression of collagen type I (COL1) in NP cells (n = 5) for each gene. Data are presented as mean ± SD. NP cells cultured in the
control medium = blue bars. NP cells cultured in the chondrogenic medium = violet bars. Scale bar: For pictures, H, until, S, the scale bar
represents 500 μm
F IGURE 6 Expression of angiopoietin-1 receptor (TEK) gene after 21 days of tri-lineage differentiation. A,B, Quantification of the relative
gene on nucleus pulposus (NP) cells (previously cultivated in two-dimensional [2D] or three-dimensional [3D]) for TEK gene after tri-lineage
differentiation. A, Relative gene expression of TEK in human bone marrow mesenchymal stromal cells (hBMSCs) and NP cells cultivated in the
adipogenic medium. B, Relative gene expression of TEK in hBMSCs and NP cells cultivated in the osteogenic medium. C, Relative gene expression
of TEK in hBMSCs and NP cells cultivated in the chondrogenic medium (n = 5) for each differentiation medium. Data are presented as mean ± SD.
NP cells cultured in control medium = blue bars. NP cells cultured in the adipogenic medium = yellow bars. NP cells cultured in the osteogenic
medium = red bars. NP cells cultured in the chondrogenic medium = violet bars
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up- or down-regulation was observed concerning adipogenic
(Figure 6A) and osteogenic (Figure 6B) differentiation for hBMSCs,
NP (2D) cells or 3D NP (3D) cells. In contrast, after 21 days of cul-
ture, we noticed a significant up-regulation (26-fold increase) of
the TEK gene (Tie2) only for NP (3D) cells cultured with
chondrogenic medium compared to ones cultured with the control
medium (Figure 6C).
3.7 | Comparison of Tie2+ and Tie2− NP cells
population
To look at the effect of Tie2+ cells on the expression of pluripotent
genes and other factors, we followed the two-step protocol previ-
ously described with the addition of a sorting step (FACS) after
digesting the NP tissue (Figure 7A). Briefly, after dissecting the human
IVD and digesting the NP tissue, NPCs were sorted for the Tie2
marker. Next, Tie2+ and Tie2− NP cells were seeded in 2D as a mono-
layer or 3D into alginate beads (Figure 7A).
We initially looked at the cell metabolism using the Alamar Blue
assay on day 4 (Figure 7B) and day 7 (Figure 7C), normalized to the
amount of DNA. We noticed that the cell metabolism (proportional to
the amount of DNA) was lower in cells (either Tie2+ or Tie2−) cultured
in 3D compared to cells cultured in 2D on day 4 and day 7 (twofold
and 3.5-fold decrease, respectively). Moreover, looking at the DNA
content at day 7 (Figure 7D), in each condition, we can observe a
lower amount of DNA measured in 3D culture (either Tie2+ or Tie2−)
compared to 2D culture (2.25-fold decrease). Concerning the GAG
load of each sample at day 7 (Figure 7E), we can note no statistical dif-
ferences between each condition (either Tie2+ or Tie2− and 2D or 3D
culture).
Regarding the relative expression of pluripotent genes and Tie2
(Figure 7F-I), the expression of NANOG (Figure 7F) and SOX2
(Figure 7H) was showing a significant up-regulation for Tie2+ NPCs
that were cultured in 3D compared to NPCs cultured in 2D (either
Tie2+ or Tie2−). However, OCT4 (Figure 7G) was not showing any sta-
tistical differences in NPCs for both conditions, so for cells cultured in
2D or 3D (either Tie2+ or Tie2−). Finally, looking at the relative gene
F IGURE 7 Comparison of nucleus pulposus (NP) cells Tie2+ and NP cells Tie2−. A, Schematic representation of the process leading to the
comparison of NP cells Tie2+ and NP cells Tie2−. Briefly, after dissection and digestion of the NP tissue from intervertebral disk (IVD), NP cells
were sorted for angiopoietin-1 receptor (Tie2) marker. Positive (Tie2+) and negative (Tie2−) cells were seeded in two-dimensional (2D) or in three-
dimensional (3D) (into alginate beads) and analyzed. A,B, Quantification of cell metabolism by Alamar Blue assay on Tie2+ and Tie2− NP cells
(cultivated in 2D or 3D) at, A, day 4 and, B, day 7. D, Quantification of GAG produced in NP cells (Tie2+ and Tie2−) in 2D or in 3D at day 7. E,
Quantification of DNA measured in NP cells (Tie2+ and Tie2−) in 2D or in 3D after day 7. F-I, Quantification of the relative gene expression on
NP cells (Tie2+ and Tie2−) after culture in 2D or in 3D for 1 week of culture. F, Relative gene expression of homeobox protein NANOG (NANOG)
in NP cells (Tie2+ and Tie2−) in 2D or in 3D. G, Relative gene expression of SRY (sex determining region Y)-box 2 (SOX2) in NP cells (Tie2+ and
Tie2−) in 2D or in 3D. H, Relative gene expression of octamer-binding transcription factor 4 (OCT4) in NP cells (Tie2+ and Tie2−) in 2D or in 3D. I,
Relative gene expression of angiopoietin-1 receptor (TEK) in NP cells (Tie2+ and Tie2−) in 2D or in 3D (n = 5) for each gene. Data are presented as
mean ± SD. Culture of NP cells (Tie2−) = blue bars. Culture of NP cells (Tie2+) = red bars
GUERRERO ET AL. 13 of 18
expression of Tie2 (aka. TEK gene) (Figure 7I), we can observe that
Tie2+ NPCs (either in 2D or 3D culture) were expressing more TEK
gene than to Tie2− NPCs (7.2- and 4.1-fold increase, for 2D and 3D
culture, respectively).
4 | DISCUSSION
In this study, we established and studied a novel and efficient two-
phase expansion culture method for human NPCs, using a series of
primary 3D alginate bead culture followed by 2D monolayer culture
on fibronectin-coated dishes with FGF-2.
In the first phase of expansion, NPCs cultured in alginate beads
(3D) showed the most relevant results. First, NPCs cultured in 3D
were showing the same phenotype as hBMSCs by expressing CD90,
CD73, CD105, and CD45 as surface markers.30 Moreover, cells cul-
tured in 3D presented a higher percentage of cells positive for CD34
(10 ± 6.2%) compared to NPCs cultured in 2D (2.5 ± 2.3%) showing a
higher potential of differentiation of this population (3D) compared to
the 2D as CD34 is a common marker for diverse progenitors.31 More-
over, the expression of the CD34 surface marker by a small percent-
age of NPCs could also suppose that those cells are closely related to
quiescent hematopoietic stem cells/progenitor cells that were identi-
fied to express both CD34 and Tie2.32-34 Only CD146 did not reveal
any differences in our analysis. This could be explained by the fact
that disks were coming from a healthy donor and that this marker can
distinguish stem cell subpopulations with distinct migration and
regenerative potential in degenerative IVDs.35 Concerning the expres-
sion of Tie2, already at the end of the first phase of expansion, the
percentage of cells expressing this NPPCs characteristic marker,7 was
much higher when cells were cultured in alginate beads than the 2D
monolayer on plastic. This observation was showing that the 3D cul-
ture was better mimicking the microenvironment of the NP tissue and
keeping NPCs in a more native surrounding inducing a higher percent-
age of Tie2 expressing cells.
Furthermore, in a matter of keeping the gene expression of plu-
ripotent genes like NANOG, SOX2, and OCT4, or by keeping the
expression of the TEK gene, the 3D configuration of NPCs was far
better than the 2D culture. Those results can be compared with the
recent use of the limiting dilution method for the isolation of rat NP
mesenchymal stem/progenitor cells (NPMSCs) and the effect
achieved in vitro on various NPMSCs biological characteristics, espe-
cially cell activity and plasticity.36
All the results and observations related to the 3D culture into
alginate beads can be possibly attributable to the fact that human NP
cells are surrounded in their native tissue by ECM and connective tis-
sues in vivo and may, therefore, favor environments in which they are
less stressed (in particular by integrin pathway). The 3D culture used
in this study maintained the NP phenotype, as confirmed by the
expression patterns of surface markers (Tie2 and CD34) and genes
(NANOG, OCT4, SOX2, and TEK).
Regarding the second phase of expansion, the addition of
FGF-2 accelerated the proliferation of human NPCs (data not
shown), as already described.37 This result is consistent with previ-
ous studies, which have reported enhanced cell proliferation follow-
ing FGF-2 administration.16,38,39 However, in agreement with
previous reports,40,41 the culture of NPCs in monolayer (2D) with or
without FGF-2 leads to a loss of the phenotype. Moreover, fibronec-
tin has been shown to be a key component in IVDs and more pre-
cisely NP tissue.42-44 In this study, the combination of fibronectin
coating with the addition of FGF-2 into the culture media, as previ-
ously described with the culture of murine NPCs, should overcome
this limitation of “stemness” potential loss.45 This expansion proto-
col, by still keeping the cells in a mimicking microenvironment after
previously cultured in 3D (alginate beads), will maintain the cells
with a phenotype and gene expression close to cells in their native
tissue. Briefly, even at the end of the second phase of expansion,
NPCs were still showing a phenotype similar to hBMSCs, meaning
CD90+, CD73+, CD105+, and CD45+. Moreover, only cells previ-
ously cultured in 3D (in the first phase) were still positive for CD34
and Tie2, two characteristic markers of NPPCs of the IVD across
species.9 However, the fibronectin coating combined with the treat-
ment with FGF-2 was not as efficient as the 3D culture in alginate,
which can be seen with a lower expression of two pluripotent genes,
NANOG and OCT4, but still a higher relative gene expression of
SOX2 and TEK for the cells previously cultured into alginate beads.
All those genes are well described for the regulation of stem cell
pluripotency and differentiation46 but are also directly described
and involved in induced pluripotent stem cells from human nucleus
pulposus cells.47
Each culture attempt (first and second expansion phase) was suc-
cessful in every trial. Despite the small number of human NPCs ini-
tially extracted after NP tissue digestion and subsequent seeding into
3D alginate beads, successful proliferation and meaningful increase of
the Tie2 expressing population was achieved. The investigation of
other markers reflecting the physiological behavior of NPCs, like the
quantification of HIF-1α, Collagen I/Collagen II ratio, or Aggrecan/
Collagen type II ratio, could have been also done to improve the qual-
ity of our study, however, due to the early time point of the analysis,
it was not possible to consider them. This lack of characterization can
be considered as a limitation for our study.
To verify the multipotent potential of the NPCs that we were
expanding, we decided to perform a tri-lineage differentiation of
those cells into adipogenic, osteogenic, and chondrogenic differentia-
tion as previously described.26,48 Osteogenic and adipogenic differen-
tiation of NPCs were performed at 20% oxygen as difficulties to
obtain mineralization and adipogenesis at low oxygen levels are well
documented in the literature.49-54 Culturing in adipogenic medium fol-
lowing a second phase expansion culture with FGF-2 was showing a
great formation of lipid droplets in our control condition (hBMSCs)
but also in both NPCs samples (2D and 3D). This was already
described in the literature55 and confirmed the stem potential of our
expanded cells. Concerning the osteogenic potential after 21 days of
culture, the NPCs (2D and 3D) also showed a strong production of
extracellular mineralized matrix, comparable to the hBMSCs. This
osteogenic potential was already described,56 however, human NPCs
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can become osteogenic in monolayer, and calcification of the extracel-
lular matrix was occurring consistently.
In previous studies, it has been reported that culturing cells in
chondrogenic medium with subsequent culture with FGF-2 increases
chondrocyte-specific gene expression and ECM synthesis.57-59 In par-
ticular, Tekari et al. showed that Tie2 expression in bovine NPCs pop-
ulation decreased from approximately 8% to less than 1% after 2.3
population doublings.8 However, Tie2+ preservation could be aug-
mented under hypoxic conditions, by supplementation of FGF-2 or
synergistic FGF-2 and hypoxic conditions.9 In this study, human NP
cells showed the appearance of “donut” like constructs after 21 days
only if cells were cultured previously into 3D alginate beads before
differentiation. Therefore, the in vitro culture into the chondrogenic
medium for pellets and micro mass in this study were able to maintain
the gene expression of TEK (Tie2) only if cells were cultured previ-
ously into 3D alginate beads prior to differentiation. These conditions
might contribute to the recovery of NPPCs even after the formation
of the NP chondrogenic pellets that we produced in vitro.
Nonetheless, the addition of TGF-β3 to the chondrogenic medium
was enhancing the production of COL10, a marker of hypertrophic dif-
ferentiation of chondrocytes. However, the relative expression of
RUNX2 was still at a relatively low level, supposing that our NP
chondrogenic pellets were potentially not reaching the stage of matrix
mineralization.
Besides, we used TGF-β3 supplemented medium during NPC cul-
ture for chondrogenic differentiation instead of TGF-β1. This resulted
in a high expression of COL10 at the end of the 21 days of differentia-
tion. However, the NP chondrogenic pellets stemming from NP cells
cultured in 3D (alginate beads) still showed a high amount of COL2
and ACAN, meaning that the hypertrophic stage was not too
advanced. Further research is needed to optimize the combined use
of growth factors required for the differentiation of NPC phenotypes.
Interestingly, the NPCs' population enriched in Tie2+ cells used
here (ie, the population with the highest percentage of Tie2+), had a
superior differentiation capacity towards the chondrogenic lineage
compared to hBMCs from the same patients as described previously
with NPCs extracted from degenerated IVD.60
This study has several limitations. First, we did not distinguish
between “notochordal cells” and “chondrocyte-like cells” among our
mix of NP cells after dissection and digestion of the NP tissue.6,61
However, morphological differences between “notochordal” cells and
“chondrocyte-like”/“nucleopulpocyte-like” cells have recently been
distinguished in the stages of cellular differentiation.6,62-67 In this
study, both large vacuolated cells and small round cells were observed
during the early stages of 3D alginate bead cultures (Figure 1). How-
ever, the small cells dominated the cell population as cell proliferation
increased. Accordingly, NP “chondrocyte-like” and NP progenitor cells
identified as small cells were mainly used in this study.
Regarding the Tie2+ and Tie2− experiment, the first phase of
expansion with 3D culture (alginate beads) seems to keep the NPCs
(either Tie2+ or Tie2−) at a lower metabolism, compared to 2D culture,
by having them in a microenvironment close to the native NP tis-
sue.68,69 Increasing evidence highlights a pivotal role for metabolism
in stem cell physiology and lineage specification.70,71 Metabolism,
indeed, is no longer considered merely an energy source nor an end-
point of gene regulation. Instead, metabolites and the nutrient envi-
ronment are active players in determining intracellular signaling and
enzymatic activities and consequently modulators of the stem cell's
fate. Moreover, metabolic intermediates of cellular metabolism regu-
late epigenetic mechanisms, including histone modifications, DNA
methylation, and noncoding RNAs, thereby modulating the global
epigenome landscape and stemness.72 Concerning GAG production
by NPCs (either Tie2+ or Tie2−), it was impossible to detect any statis-
tical difference probably due to the early time point of measurement
(day 7), knowing that it was early shown that ECM mimicking scaffold
(including GAG) promote stemness maintenance of mesenchymal
stem cells via spheroid formation.73 Recent research showed that the
enrichment of the culture environment, either by chemically defined
medium, growth factor supplementation, or modification of the cul-
ture surface stiffness, helped to preserve progenitor cells.74,75
Concerning the pluripotent gene expression for NP Tie2+ and
Tie2− cells, the higher expression of NANOG and SOX2 only found in
NPCs positive for Tie2 and cultured in 3D reveals the central role of
3D mimicking microenvironment for NPPCs culture. Even if in 2D,
during the first phase of expansion Tie2+ cells were still expressing
the TEK gene (aka. Tie2), they were however not able to maintain any
of their pluripotent gene expression, as described with hBMSCs.76
Our method has the potential to become a useful tool for basic
research and clinical research (cell therapy) aiming at elucidating
molecular mechanisms in human NPCs and in developing cell-based
regenerative therapies for IVD degeneration using expanded NPCs
population enriched in NPPCs (Tie2+), which cannot be obtained using
a conventional monolayer culture method.77 Furthermore, it will be
useful for research related to tissue engineering or regenerative medi-
cine in which the expansion of progenitor cells plays an
important role.
5 | CONCLUSIONS
We established a novel and efficient primary culture and expansion
culture method for human NPCs consisting of sequential primary 3D
alginate culture with ascorbic acid supplemented medium followed by
2D monolayer culture on fibronectin-coated dishes containing FGF-2.
This protocol shows that heterogenic NP cell populations are closer to
a multipotent phenotype if cultured in 3D within alginate beads com-
pared to 2D culture. Moreover, NPCs were able to better differentiate
into osteogenic, chondrogenic, and to a lesser extent adipogenic line-
age even after in vitro expansion than 2D monolayer expanded NPCs.
As we experimented with pure Tie2+ and Tie2− cell populations, it is
highly suggested that the maintenance of multipotent capacity was
mainly but not exclusively due to the higher presence of Tie2+ cells in
the 3D culture. This project not only has a scientific impact by evalu-
ating the influence of a two-step expansion protocol on the function-
ality of NP progenitors but could also lead to an innovative clinical
approach with cell therapy for IVD regeneration and repair.
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